• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER

    6/12/25 10:05:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance
    Get the next $TROW alert in real time by email

    The T. Rowe Price Financials ETF, Health Care ETF and Natural Resources ETF began trading today and expanded the firm's ETF lineup to 22

    BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds (ETF): T. Rowe Price Financials ETF (Ticker: TFNS), T. Rowe Price Health Care ETF (Ticker: TMED), and T. Rowe Price Natural Resources ETF (Ticker: TURF). The new funds began trading on NASDAQ today. T. Rowe Price's active ETF roster now sits at 22 offerings.

    T. Rowe Price Logo (PRNewsfoto/T. Rowe Price Group)

    Each of the three funds represents new and distinct strategies and has an expense ratio of 0.44%. The ETFs seek to provide long-term capital appreciation growth through exposure to their respective sectors:

    T. Rowe Price Financials ETF (TFNS) invests at least 80 percent of its net assets in securities of companies servicing and operating in the financial services industry and typically maintains a portfolio of 50-70 companies. TFNS is managed by Matt Snowling, CFA® and Greg Locraft, two portfolio managers of the T. Rowe Price Financial Services Equity strategy.

    T. Rowe Price Health Care ETF (TMED) invests at least 80 percent of its net assets in the securities of health care companies engaged in health care innovations. The fund's portfolio typically consists of 100 to 150 stocks and is diversified across health care, with a focus on biotechnology, pharmaceuticals, products and device providers, and health care service companies. TMED will be co-managed by Sal Rais, who covers biotech companies, and Jon Wood, who covers life science and diagnostic tools, and medical supplies and devices.

    T. Rowe Price Natural Resources ETF (TURF) invests at least 80 percent of its net assets in the securities of natural resource companies, with primary focus on those engaged in the upstream extraction of energy, minerals and agriculture products. The fund typically holds 60-80 securities and invests in resource companies on a global basis. TURF is co-managed by five investment professionals:

    • Rick de los Reyes, head of Commodities; and portfolio manager, Global Natural Resources Equity strategy
    • Shinwoo Kim, portfolio manager, Global Natural Resources Equity strategy
    • Priyal Maniar, CFA®, co-portfolio manager, TURF ETF; and investment analyst, North America Energy
    • John Qian, portfolio manager, Metals and Mining strategy
    • Tom Shelmerdine, portfolio manager, Precious Metals strategy

    T. Rowe Price introduced its first active ETFs in 2020, and today's launches bring the firm's lineup to 16 equity active ETFs and six fixed income active ETFs. The funds deliver key features associated with ETFs such as tax efficiency, more competitive expense ratios, and the flexibility to buy and sell shares throughout the trading day. Designed to outperform passive indexes, each T. Rowe Price active ETF applies the longstanding investing capabilities of the firm's active managers, based on rigorous global research and the regular practice of asking better questions, as they strive to deliver better investment outcomes for clients.

    QUOTE:

    Tim Coyne, Global Head of Exchange-Traded Funds

    "The launches of TMED, TURF, and TFNS reflect our ongoing commitment to deliver an array of active ETFs that meet the evolving needs of our clients. We remain focused on growing our active ETF business and look forward to continuing to build it with compelling investing ideas and the best thinking of T. Rowe Price active managers."

    ABOUT T. ROWE PRICE

    Founded in 1937, T. Rowe Price (NASDAQ:TROW) helps people around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Investors rely on the award-winning firm for its retirement expertise and active management approach of equity, fixed income, alternatives, and multi-asset investment capabilities. T. Rowe Price manages USD $1.62 trillion in assets under management as of May 31, 2025, and serves millions of clients globally. News and other updates can be found on Facebook, Instagram, LinkedIn, Twitter, YouTube, and troweprice.com/newsroom.

    Consider the investment objectives, risks, and charges and expenses carefully before investing. For a prospectus or, if available, a summary prospectus containing this and other information visit troweprice.com. Read it carefully.

    ETFs are bought and sold at market prices, not net asset value (NAV). Investors generally incur the cost of the spread between the prices at which shares are bought and sold. Buying and selling shares may result in brokerage commissions which will reduce returns.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/t-rowe-price-adds-three-new-transparent-sector-offerings-to-its-active-etf-roster-302480313.html

    SOURCE T. Rowe Price Group

    Get the next $TROW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TROW

    DatePrice TargetRatingAnalyst
    10/3/2025$108.00Market Perform
    BMO Capital Markets
    9/12/2024$109.00Equal Weight
    Wells Fargo
    8/27/2024$99.00Underweight
    Barclays
    4/11/2024$106.00 → $120.00Underperform → Mkt Perform
    Keefe Bruyette
    4/8/2024$92.00 → $114.00Sell → Hold
    TD Cowen
    1/8/2024$95.00 → $105.00Equal Weight → Underweight
    Wells Fargo
    1/4/2024$88.00Underperform
    TD Cowen
    10/31/2023$100.00 → $95.00Sell → Neutral
    Citigroup
    More analyst ratings

    $TROW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wilson Alan D

    4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    3/31/26 12:33:45 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by Wijnberg Sandra S

    4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    3/31/26 12:33:28 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by Verma Richard R.

    4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    3/31/26 12:33:10 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on T. Rowe Price with a new price target

    BMO Capital Markets initiated coverage of T. Rowe Price with a rating of Market Perform and set a new price target of $108.00

    10/3/25 8:45:55 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Wells Fargo initiated coverage on T. Rowe Price with a new price target

    Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00

    9/12/24 9:14:34 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Barclays initiated coverage on T. Rowe Price with a new price target

    Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00

    8/27/24 7:37:56 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NEW T. ROWE PRICE PODCAST EPISODE EXAMINES THE FUTURE OF AI AND HUMAN ADVANTAGE

    A conversation on AI, curiosity, and the skills that endure BALTIMORE, April 2, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and leader in retirement, announces a new episode of "The Angle from T. Rowe Price," its investment-themed podcast focused on the ideas and events influencing financial markets. In the episode, "Humans vs. Machines: David Rowan on Curiosity, Creativity, and the Future of AI," Justin Thomson, head of the T. Rowe Price Investment Institute, sits down with David Rowan, technology journalist, investor, and founding editor-in-chief of

    4/2/26 9:30:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE NAMES BILL CASHEL AS HEAD OF ALTERNATIVES FOR ITS WEALTH CHANNEL

    New leadership role strengthens intermediary engagement and advances firm's growing alternatives offeringBALTIMORE, March 31, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, announced today that Bill Cashel has joined the firm as Head of Alternatives for U.S. Wealth. The appointment comes at a time of notable development within T. Rowe Price's alternatives business, as the firm continues to expand its private markets offerings and the alternatives team that supports them. In his new role, Cashel will work closely with sales tea

    3/31/26 10:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE EXPLORES LEADERSHIP, TRANSFORMATION, AND THE FUTURE OF MOBILITY WITH FORD CEO JIM FARLEY

    Newest episode of "The Angle" from T. Rowe Price features a candid conversation on strategic reinvention, electrification realities, and leading with urgency and purposeBALTIMORE, March 25, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, announced the latest episode of "The Angle from T. Rowe Price," an investment-themed podcast focused on the forces shaping financial markets and the leaders navigating them. In the newest episode, host Eric Veiel, Head of Global Investments and Chief Investment Officer for T. Rowe Price, sits d

    3/25/26 9:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by T. Rowe Price Group Inc.

    SCHEDULE 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    3/27/26 1:19:17 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form DEFA14A filed by T. Rowe Price Group Inc.

    DEFA14A - PRICE T ROWE GROUP INC (0001113169) (Filer)

    3/17/26 6:20:55 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form DEF 14A filed by T. Rowe Price Group Inc.

    DEF 14A - PRICE T ROWE GROUP INC (0001113169) (Filer)

    3/17/26 6:16:34 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Financials

    Live finance-specific insights

    View All

    T. ROWE PRICE GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

    BALTIMORE, Feb. 4, 2026 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced its financial results for the fourth quarter and full year 2025. The earnings release can be found on the firm's website at troweprice.com/newsroom. Chair, CEO, and President Rob Sharps and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast today from 8:00 - 8:45 AM (Eastern Time). To access the webcast or to obtain dial-in instructions to ask a question, please visit investors.troweprice.com.

    2/4/26 7:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE GROUP REPORTS THIRD QUARTER 2025 RESULTS

    BALTIMORE, Oct. 31, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced its financial results for the third quarter of 2025. The earnings release can be found on the firm's website at troweprice.com/newsroom. Chair, Chief Executive Officer, and President Rob Sharps and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast today from 8:00 - 8:45 AM ET. To access the webcast or to obtain dial-in instructions to ask a question, please visit investors.troweprice.com. Sup

    10/31/25 7:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND

    BALTIMORE, Oct. 28, 2025 /PRNewswire/ -- T. Rowe Price Group (NASDAQ-GS: TROW), a global asset management firm and a leader in retirement, announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable on December 30, 2025, to stockholders of record as of the close of business on December 15, 2025. ABOUT T. ROWE PRICE T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm entrusted with managing $1.77 trillion in client assets as of September 30, 2025, about two-thirds of which are retirement-related. Renowned for ov

    10/28/25 12:20:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Leadership Updates

    Live Leadership Updates

    View All

    Longeviti Neuro Solutions Appoints T. Rowe Price CEO Robert W. Sharps to Board of Directors

    BALTIMORE, March 20, 2026 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company developing advanced implantable and AI-enabled solutions for neurological health including the ClearFit AI™, the first Acoustic Brain Interface (ABI)™, today announced the appointment of Robert W. Sharps, Chief Executive Officer and President of T. Rowe Price Group, Inc. (NASDAQ:TROW), to its Board of Directors. Sharps brings three decades of leadership experience in global asset management, capital markets, corporate governance, and strategic growth. As CEO and the Chairman of the Board of T. Rowe Price, he oversees one of the world's leading investment firms, managing more than $1.5 trilli

    3/20/26 10:48:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    STEPH JACKSON TO RETIRE FROM T. ROWE PRICE INVESTMENT MANAGEMENT

    Steven Krichbaum named successor and new head of TRPIM in 2027 BALTIMORE, Jan. 22, 2026 /PRNewswire/ -- T. Rowe Price announced today a planned leadership transition within its T. Rowe Price Investment Management division (TRPIM), as Steph Jackson, who currently serves as head of TRPIM and is a member of the Management Committee, will be retiring at the end of 2026. Jackson's tenure at T. Rowe Price has been marked by impactful leadership and a steadfast commitment to clients, associates, and community. Since joining T. Rowe Price in 2007, Jackson has held influential roles,

    1/22/26 8:45:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    $TROW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    2/13/24 4:55:53 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    1/29/24 12:09:07 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    2/10/23 12:26:32 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance